http://www.surfaceoncology.com
Surface Oncology, Inc. Company Intro
Surface Oncology is developing next generation immunotherapies that target the immune-suppressive tumor microenvironment to attack cancer.
Industry
Healthcare
Surface Oncology, Inc. Headquaters
50 Hampshire Street
Cambridge,02139
United States
Surface Oncology, Inc. Share price
14 Sep 2022 10:20 GMT
$1.3500
-0.05 (-3.57 %)
Surface Oncology, Inc. Market cap
$60.898 M
WMC RANKING
2023
Surface Oncology, Inc. # 108
BiotechnologyLatest Surface Oncology, Inc. News
02 Feb 2023
Surface Oncology to Participate in the 2023 Guggenheim ...
Surface Oncology is an immuno-oncology company developing next-generation antibody therapies focused on the tumor microenvironment.
02 Feb 2023
2023-02-02 | NDAQ:SURF | Press Release | Surface ...
Surface Oncology is an immuno-oncology company developing next-generation antibody therapies focused on the tumor microenvironment. Its pipeline includes two...
02 Feb 2023
AviadoBio Announces Appointment of Jeff Goater as Chair of ...
SURFACE ONCOLOGY, INC. : Notice of Delisting or Failure to Satisfy a... 01/09. Vaccinex Announces First Patient Dosed with Anti-CCR8 Antibody Licensed to.
WMC Market Score
WMC Market to Revenue Score
Surface Oncology, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Surface Oncology, Inc. | USD | $89,196 | $64,686 | $21,206 | $609M | 108 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Surface Oncology, Inc. Social Followers vs Top 4 Industry Competitors
Surface Oncology, Inc. Post vs Top 4 Industry Competitors
Surface Oncology, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Surface Oncology, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Surface Oncology, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Surface Oncology, Inc. | 0.97 | 0.16 | 24.52 | 0 | 0 | 0 | 11.13 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
